FDA Joins GIZ To Train Health Workers On vaccine Safety Knowledge
The Food and Drugs Authorities (FDA), in partnership with the German Agency for International Co-operation, GIZ, has trained three hundred and twenty-eight (328) health professionals made including doctors, pharmacists, and nurses on vaccine safety.
The participants are part of the Institutional Contact Persons in different facilities across the 16 regions of Ghana who work closely with the Food and Drugs Authority [FDA]. They are from government hospitals and Christian Health Association Ghana-run facilities. Their main aim is to shape their knowledge and scale on vaccine doubt.
The participants were trained on assessment and vaccine safety monitoring systems in Ghana, vaccine development and efficiency, and basic concepts of Adverse Events Following Immunization [AEFI].
The FDA Regional Head of Bono Region, who is also in charge of Ahafo and Bono East Regions, Akosua Amponsaa Owusu explained, “When people come after the jab that they are dizzy, have a swelling, a headache, what are you supposed to do? They are trained on how to maintain, report, and manage versus events following immunization.”
She said, “all the region has a six-member team made up of clinicians, pharmacists and lab technicians, FDA.”
“If there is a hinder effect, they need to investigate and then report to the technical advisory committee at FDA headquarters to determine the cause and then advise on what to do.”
The training is to enhance their knowledge in vaccine development and administration so that healthcare professionals will be better equipped to convince patients to take vaccines and also serve as trainers of trainees and their colleagues workers in the institutions.
Madam Akosua Amponsaa Owusu said, “When people take for instance the Covid-19 vaccine, they react, no matter how small, healthcare professionals must report. If I come with a headache, you just don’t say this is nothing and if you sleep small, it’ll go. Just take the needed information because that also helps in the vaccine redevelopment. We need this concrete evidence which comes together as data to determine whether for instance vaccine must be readjusted for Africans.”
The project is funded by the development program and implemented by GIZ on behalf of the German Federal Ministry of Economic Co-operation and Development.